Skip to main content

Health In Tech, Inc.

For the period ended Sep 30, 2026. Filed Sep 30, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Sep 30, 2026 · Filed Sep 30, 2026

Use the contents to explore the available documents and sections.

HIT$0.56-3.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Solving a Complex Large-Group Workflow

Solving a Complex Large-Group Workflow

For brokers serving larger employers, bringing a case to market can require collecting significant volumes of employee census information, claims data, plan documents and other sensitive information; organizing files received in multiple formats; preparing submissions for different carriers and managing general underwriters (“MGUs”); tracking responses; and manually comparing proposals.HitRix is designed to simplify that process.

Through HitRix, brokers can securely upload case information in the formats in which they receive it. HitRix uses AI-powered document intelligence to ingest, extract, organize and structure the information, reducing the need for manual data entry and reformatting.

The platform then enables brokers to manage submissions across multiple carriers and MGUs, track market activity in one environment, organize incoming proposals and compare alternatives more efficiently.

By reducing repetitive administrative work, HitRix is designed to allow brokers to spend more time advising clients and less time managing documents, spreadsheets, emails and multiple insurance portals.

Unlike traditional submission tools focused primarily on document routing or RFP management, HitRix is integrated with Health In Tech’s broader underwriting and marketplace infrastructure, connecting submission, market access, analytics and transaction execution within one environment.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.